Vault-13

Parkman Healthcare Partners LLC

STAMFORD, CT · CIK 1777015 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2019 · limited liability company

$973.7m reported value +0.9% vs Q1 2026
76positions
33.6%in top 10
17 new 27 added 30 reduced 30 sold out vs Q1 2026

Options: 0 call positions (— notional), 1 put positions ($3.1m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MBX BIOSCIENCES INC COM MBX MBX 800,173 $44.2m4.54% 4.54% AddedShares held: Q3 2025 773.3k, Q4 2025 885.6k, Q1 2026 800.0k, Q2 2026 800.2k +136 +136 0.0%
2 ELI LILLY & CO COM LLY LLY 35,000 $42.0m4.31% 4.31% AddedShares held: Q3 2025 10.0k, Q4 2025 0, Q1 2026 34.6k, Q2 2026 35.0k +384 +384 1.1%
3 CVS HEALTH CORP COM CVS CVS 391,791 $40.5m4.16% 4.16% AddedShares held: Q3 2025 379.5k, Q4 2025 450.2k, Q1 2026 387.3k, Q2 2026 391.8k +4.5k +4,485 1.2%
4 DEXCOM INC COM DXCM DXCM 534,767 $36.0m3.70% 3.70% ReducedShares held: Q3 2025 171.6k, Q4 2025 587.5k, Q1 2026 689.8k, Q2 2026 534.8k -155.1k -155,055 -22.5%
5 PTC THERAPEUTICS INC COM PTCT PTCT 435,691 $35.5m3.65% 3.65% AddedShares held: Q3 2025 202.4k, Q4 2025 160.2k, Q1 2026 431.4k, Q2 2026 435.7k +4.3k +4,327 1.0%
6 ARCUS BIOSCIENCES INC COM RCUS RCUS 919,266 $28.3m2.91% 2.91% ReducedShares held: Q3 2025 652.7k, Q4 2025 968.6k, Q1 2026 1.2m, Q2 2026 919.3k -288.0k -288,008 -23.9%
7 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 485,661 $26.1m2.68% 2.68% AddedShares held: Q3 2025 0, Q4 2025 55.0k, Q1 2026 232.1k, Q2 2026 485.7k +253.6k +253,568 109.2%
8 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,377,576 $25.3m2.60% 2.60% AddedShares held: Q3 2025 1.2m, Q4 2025 788.1k, Q1 2026 557.9k, Q2 2026 1.4m +819.6k +819,640 146.9%
9 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 669,046 $24.8m2.55% 2.55% AddedShares held: Q3 2025 100.4k, Q4 2025 99.6k, Q1 2026 403.5k, Q2 2026 669.0k +265.5k +265,521 65.8%
10 INHIBRX BIOSCIENCES INC COM INBX INBX 256,950 $24.3m2.50% 2.50% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 256.9k
11 XENON PHARMACEUTICALS INC COM XENE XENE 397,379 $24.0m2.46% 2.46% ReducedShares held: Q3 2025 176.1k, Q4 2025 154.2k, Q1 2026 497.0k, Q2 2026 397.4k -99.7k -99,656 -20.1%
12 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 577,036 $23.4m2.41% 2.41% AddedShares held: Q3 2025 550.2k, Q4 2025 427.7k, Q1 2026 322.8k, Q2 2026 577.0k +254.2k +254,208 78.7%
13 UNITEDHEALTH GROUP INC COM UNH UNH 55,921 $23.2m2.39% 2.39% NewShares held: Q3 2025 0, Q4 2025 31.9k, Q1 2026 0, Q2 2026 55.9k
14 STRYKER CORPORATION COM SYK SYK 67,973 $21.4m2.20% 2.20% ReducedShares held: Q3 2025 64.1k, Q4 2025 105.5k, Q1 2026 154.8k, Q2 2026 68.0k -86.8k -86,798 -56.1%
15 IQVIA HLDGS INC COM IQV IQV 105,811 $20.4m2.10% 2.10% AddedShares held: Q3 2025 30.0k, Q4 2025 35.2k, Q1 2026 86.7k, Q2 2026 105.8k +19.1k +19,109 22.0%
16 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 232,557 $20.0m2.06% 2.06% ReducedShares held: Q3 2025 251.4k, Q4 2025 151.0k, Q1 2026 269.6k, Q2 2026 232.6k -37.0k -37,000 -13.7%
17 INSULET CORP COM PODD PODD 131,378 $20.0m2.05% 2.05% ReducedShares held: Q3 2025 116.2k, Q4 2025 140.9k, Q1 2026 156.6k, Q2 2026 131.4k -25.2k -25,183 -16.1%
18 ASSEMBLY BIOSCIENCES INC COM NEW ASMB ASMB 721,181 $19.8m2.04% 2.04% AddedShares held: Q3 2025 251.0k, Q4 2025 249.4k, Q1 2026 411.2k, Q2 2026 721.2k +310.0k +309,954 75.4%
19 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 877,256 $19.2m1.97% 1.97% ReducedShares held: Q3 2025 846.9k, Q4 2025 574.0k, Q1 2026 901.5k, Q2 2026 877.3k -24.3k -24,255 -2.7%
20 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 1,288,163 $18.4m1.89% 1.89% ReducedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 1.4m, Q2 2026 1.3m -66.6k -66,637 -4.9%
21 TENET HEALTHCARE CORP COM NEW THC THC 97,280 $18.2m1.87% 1.87% AddedShares held: Q3 2025 74.3k, Q4 2025 60.5k, Q1 2026 50.1k, Q2 2026 97.3k +47.2k +47,157 94.1%
22 LIVANOVA PLC SHS LIVN LIVN 210,529 $17.3m1.78% 1.78% ReducedShares held: Q3 2025 275.8k, Q4 2025 410.9k, Q1 2026 404.0k, Q2 2026 210.5k -193.4k -193,436 -47.9%
23 ANI PHARMACEUTICALS INC COM ANIP ANIP 202,907 $16.8m1.73% 1.73% ReducedShares held: Q3 2025 0, Q4 2025 145.0k, Q1 2026 280.6k, Q2 2026 202.9k -77.7k -77,668 -27.7%
24 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,624,279 $16.2m1.67% 1.67% ReducedShares held: Q3 2025 1.0m, Q4 2025 900.1k, Q1 2026 1.7m, Q2 2026 1.6m -83.8k -83,820 -4.9%
25 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 50,672 $15.3m1.57% 1.57% AddedShares held: Q3 2025 87.7k, Q4 2025 47.7k, Q1 2026 26.9k, Q2 2026 50.7k +23.8k +23,756 88.3%
26 INDIVIOR PHARMACEUTICALS INC COM INDV INDV 364,269 $14.9m1.53% 1.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 364.3k
27 ENVISTA HOLDINGS CORPORATION COM NVST NVST 553,916 $14.6m1.50% 1.50% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 711.7k, Q2 2026 553.9k -157.8k -157,777 -22.2%
28 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 205,053 $14.4m1.48% 1.48% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 40.1k, Q2 2026 205.1k +165.0k +164,955 411.4%
29 XERIS BIOPHARMA HOLDINGS INC COM XERS XERS 1,807,621 $14.3m1.47% 1.47% AddedShares held: Q3 2025 1.8m, Q4 2025 1.7m, Q1 2026 1.7m, Q2 2026 1.8m +86.4k +86,357 5.0%
30 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 766,290 $14.2m1.45% 1.45% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 766.3k
31 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 948,184 $12.6m1.30% 1.30% AddedShares held: Q3 2025 200.0k, Q4 2025 503.4k, Q1 2026 522.6k, Q2 2026 948.2k +425.6k +425,607 81.4%
32 IMMUNOME INC COM IMNM IMNM 594,202 $12.6m1.29% 1.29% AddedShares held: Q3 2025 351.1k, Q4 2025 277.8k, Q1 2026 403.5k, Q2 2026 594.2k +190.7k +190,715 47.3%
33 STOKE THERAPEUTICS INC COM STOK STOK 355,443 $11.6m1.19% 1.19% AddedShares held: Q3 2025 250.0k, Q4 2025 430.2k, Q1 2026 336.5k, Q2 2026 355.4k +18.9k +18,924 5.6%
34 WATERS CORP COM WAT WAT 30,206 $11.3m1.16% 1.16% AddedShares held: Q3 2025 0, Q4 2025 41.9k, Q1 2026 26.4k, Q2 2026 30.2k +3.8k +3,759 14.2%
35 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 429,035 $11.3m1.16% 1.16% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 429.0k
36 ORUKA THERAPEUTICS INC COM ORKA ORKA 113,188 $10.8m1.11% 1.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 113.2k
37 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 486,984 $10.4m1.07% 1.07% ReducedShares held: Q3 2025 0, Q4 2025 401.7k, Q1 2026 551.8k, Q2 2026 487.0k -64.8k -64,831 -11.8%
38 ABSCI CORPORATION COM ABSI ABSI 894,374 $10.4m1.06% 1.06% ReducedShares held: Q3 2025 0, Q4 2025 1.5m, Q1 2026 1.9m, Q2 2026 894.4k -970.4k -970,432 -52.0%
39 MINERALYS THERAPEUTICS INC COM MLYS MLYS 380,354 $10.3m1.05% 1.05% AddedShares held: Q3 2025 455.5k, Q4 2025 410.2k, Q1 2026 380.1k, Q2 2026 380.4k +217 +217 0.1%
40 COGENT BIOSCIENCES INC COM COGT COGT 253,365 $9.8m1.01% 1.01% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 100.1k, Q2 2026 253.4k +153.2k +153,239 153.1%
41 UNIQURE NV SHS QURE QURE 208,170 $9.6m0.98% 0.98% AddedShares held: Q3 2025 345.4k, Q4 2025 257.4k, Q1 2026 206.8k, Q2 2026 208.2k +1.3k +1,328 0.6%
42 TARSUS PHARMACEUTICALS INC COM TARS TARS 150,000 $9.4m0.97% 0.97% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 150.0k
43 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 541,190 $9.4m0.96% 0.96% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 300.8k, Q2 2026 541.2k +240.4k +240,438 80.0%
44 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 67,267 $8.0m0.82% 0.82% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 40.1k, Q2 2026 67.3k +27.1k +27,142 67.6%
45 CRYOPORT INC COM PAR $0.001 CYRX CYRX 508,324 $8.0m0.82% 0.82% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 508.3k
46 BOSTON SCIENTIFIC CORP COM BSX BSX 180,481 $7.7m0.79% 0.79% ReducedShares held: Q3 2025 434.4k, Q4 2025 500.5k, Q1 2026 448.8k, Q2 2026 180.5k -268.3k -268,287 -59.8%
47 CLIMB BIO INC COM CLYM CLYM 563,484 $7.3m0.75% 0.75% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 563.5k
48 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 398,782 $7.2m0.74% 0.74% ReducedShares held: Q3 2025 579.2k, Q4 2025 381.8k, Q1 2026 621.5k, Q2 2026 398.8k -222.7k -222,676 -35.8%
49 UPSTREAM BIO INC COM UPB UPB 935,247 $6.5m0.66% 0.66% AddedShares held: Q3 2025 843.5k, Q4 2025 834.6k, Q1 2026 786.8k, Q2 2026 935.2k +148.5k +148,464 18.9%
50 RESMED INC COM RMD RMD 32,983 $6.4m0.66% 0.66% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 33.0k
51 UROGEN PHARMA LTD COM URGN URGN 174,064 $6.4m0.66% 0.66% ReducedShares held: Q3 2025 402.6k, Q4 2025 168.8k, Q1 2026 275.0k, Q2 2026 174.1k -100.9k -100,936 -36.7%
52 ALIGN TECHNOLOGY INC COM ALGN ALGN 36,963 $6.2m0.64% 0.64% AddedShares held: Q3 2025 0, Q4 2025 25.3k, Q1 2026 21.2k, Q2 2026 37.0k +15.7k +15,730 74.1%
53 CARLSMED INC COM CARL CARL 597,318 $6.2m0.64% 0.64% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 521.1k, Q2 2026 597.3k +76.2k +76,195 14.6%
54 AVEANNA HEALTHCARE HLDGS INC COM AVAH AVAH 714,451 $6.1m0.63% 0.63% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 714.5k
55 CAREDX INC COM CDNA CDNA 202,417 $5.8m0.59% 0.59% ReducedShares held: Q3 2025 0, Q4 2025 276.2k, Q1 2026 291.4k, Q2 2026 202.4k -89.0k -88,961 -30.5%
56 SI-BONE INC COM SIBN SIBN 328,686 $5.4m0.55% 0.55% ReducedShares held: Q3 2025 378.6k, Q4 2025 374.4k, Q1 2026 373.6k, Q2 2026 328.7k -44.9k -44,867 -12.0%
57 VIR BIOTECHNOLOGY INC COM VIR VIR 475,279 $4.8m0.50% 0.50% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 500.0k, Q2 2026 475.3k -24.7k -24,721 -4.9%
58 ERASCA INC COM ERAS ERAS 258,684 $4.7m0.49% 0.49% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 406.7k, Q2 2026 258.7k -148.0k -148,018 -36.4%
59 SHOULDER INNOVATIONS INC COMMON STOCK SI SI 226,212 $4.6m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 226.2k
60 WAYSTAR HLDG CORP COM WAY WAY 203,986 $4.2m0.43% 0.43% ReducedShares held: Q3 2025 306.0k, Q4 2025 369.0k, Q1 2026 443.1k, Q2 2026 204.0k -239.1k -239,072 -54.0%
61 ALPHATEC HLDGS INC COM NEW ATEC ATEC 449,943 $3.9m0.40% 0.40% ReducedShares held: Q3 2025 697.0k, Q4 2025 277.2k, Q1 2026 823.8k, Q2 2026 449.9k -373.8k -373,820 -45.4%
62 ANNEXON INC COM ANNX ANNX 641,029 $3.7m0.38% 0.38% ReducedShares held: Q3 2025 406.0k, Q4 2025 601.2k, Q1 2026 674.0k, Q2 2026 641.0k -33.0k -32,984 -4.9%
63 CASTLE BIOSCIENCES INC COM CSTL CSTL 144,791 $3.5m0.35% 0.35% AddedShares held: Q3 2025 475.6k, Q4 2025 150.6k, Q1 2026 126.2k, Q2 2026 144.8k +18.6k +18,641 14.8%
64 MINIMED GROUP INC COM MMED MMED 226,446 $3.4m0.35% 0.35% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 317.3k, Q2 2026 226.4k -90.9k -90,878 -28.6%
65 EIKON THERAPEUTICS INC COM EIKN EIKN 256,053 $3.3m0.34% 0.34% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 256.1k
66 VIATRIS INC COM VTRS VTRS 200,000 $3.2m0.33% 0.33% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
67 ARTIVION INC COM AORT AORT 138,940 $3.1m0.32% 0.32% ReducedShares held: Q3 2025 221.0k, Q4 2025 218.7k, Q1 2026 252.0k, Q2 2026 138.9k -113.1k -113,074 -44.9%
68 AXSOME THERAPEUTICS INC COM AXSM AXSM 10,000 $2.4m0.25% 0.25% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.0k
69 OPTIMIZERX CORP COM NEW OPRX OPRX 350,347 $2.0m0.21% 0.21% ReducedShares held: Q3 2025 509.6k, Q4 2025 538.6k, Q1 2026 729.4k, Q2 2026 350.3k -379.0k -379,022 -52.0%
70 INSPIREMD INC COM NSPR NSPR 2,416,518 $1.7m0.17% 0.17% UnchangedShares held: Q3 2025 2.4m, Q4 2025 2.4m, Q1 2026 2.4m, Q2 2026 2.4m
71 HEMAB THERAPEUTICS HLDGS INC COM SHS COAG COAG 45,000 $1.7m0.17% 0.17% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 45.0k
72 PULMONX CORP COM LUNG LUNG 646,564 $840.5k0.09% 0.09% ReducedShares held: Q3 2025 500.7k, Q4 2025 727.8k, Q1 2026 755.6k, Q2 2026 646.6k -109.1k -109,072 -14.4%
73 ARS PHARMACEUTICALS INC COM SPRY SPRY 102,700 $822.6k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 102.7k
74 EDAP TMS S A SPONSORED ADR FOCL FOCL 154,832 $802.0k0.08% 0.08% UnchangedShares held: Q3 2025 154.8k, Q4 2025 154.8k, Q1 2026 154.8k, Q2 2026 154.8k
75 OVID THERAPEUTICS INC COM OVID OVID 197,947 $532.5k0.05% 0.05% ReducedShares held: Q3 2025 203.0k, Q4 2025 201.0k, Q1 2026 208.2k, Q2 2026 197.9k -10.3k -10,258 -4.9%
76 ENTERA BIO LTD SHS ENTX ENTX 274,497 $485.9k0.05% 0.05% ReducedShares held: Q3 2025 280.8k, Q4 2025 275.1k, Q1 2026 288.7k, Q2 2026 274.5k -14.2k -14,173 -4.9%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
KALVISTA PHARMACEUTICALS INC KALV KALV 1,835,506 $36.9m1.8m shares
QIAGEN NV QGEN QGEN 500,000 $20.0m500.0k shares
ABBVIE INC ABBV ABBV 75,000 $16.3m75.0k shares
ILLUMINA INC ILMN ILMN 110,370 $13.6m110.4k shares
EDWARDS LIFESCIENCES CORP EW EW 167,155 $13.4m167.2k shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 99,069 $13.1m99.1k shares
KINIKSA PHARMACEUTICALS INTL KNSA KNSA 259,184 $12.5m259.2k shares
MCKESSON CORP MCK MCK 12,676 $11.0m12.7k shares
NUVALENT INC 88,078 $9.0m88.1k shares
AXOGEN INC AXGN AXGN 268,160 $8.9m268.2k shares
IDEXX LABS INC IDXX IDXX 15,000 $8.4m15.0k shares
APOGEE THERAPEUTICS INC 77,686 $6.5m77.7k shares
COOPER COS INC COO COO 89,883 $6.4m89.9k shares
TANGO THERAPEUTICS INC TNGX TNGX 266,127 $5.6m266.1k shares
ULTRAGENYX PHARMACEUTICAL IN RARE RARE 235,000 $4.9m235.0k shares
SUPERNUS PHARMACEUTICALS INC SUPN SUPN 85,062 $4.4m85.1k shares
CARIS LIFE SCIENCES INC CAI CAI 229,912 $4.1m229.9k shares
CVRX INC CVRX CVRX 429,507 $4.1m429.5k shares
GENEDX HOLDINGS CORP WGS WGS 50,778 $3.3m50.8k shares
VERACYTE INC VCYT VCYT 101,237 $3.3m101.2k shares
COMPASS PATHWAYS PLC CMPS CMPS 554,411 $3.1m554.4k shares
SOLID BIOSCIENCES INC SLDB SLDB 308,844 $2.2m308.8k shares
BUTTERFLY NETWORK INC BFLY BFLY 544,477 $2.2m544.5k shares
QUIDELORTHO CORP QDEL QDEL 101,764 $1.7m101.8k shares
RXSIGHT INC RXST RXST 249,989 $1.5m250.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
GRAIL INC GRAL · Put GRALPut 46,000 $3.1m46.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
INSPIREMD INC NSPR · 13G · filed 2025-11-14 NSPR 5.8%≈ $1.7m new 13G 2025-11-14